Search - tctmd.com

Displaying 61 - 80 of 174

Sort: Relevancy | Date

News Daily News

TAVR Learning Curve, Volume-Outcome Relationship Highlighted in International Registry

Todd Neale

September 11, 2018

News Daily News

‘We Have to Go to Them’: New Global Initiative for Treating Rheumatic Heart Disease

Michael O'Riordan

August 06, 2018

News Daily News

Updated TAVR Consensus Statement Keeps Volume Requirements but Shifts Focus to Quality

Todd Neale

July 18, 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Michael O'Riordan

June 22, 2018

News Features

Cardiologists Treating Syrian Refugees Call Missions an ‘Addictive’ Passion That Saves Lives

Yael L. Maxwell

January 12, 2018

News Daily News

Low Rate of Bailout Emergency Surgery During TAVR, but Caution Still Needed

Michael O'Riordan

January 10, 2018

News Conference News TCT 2017

3-D Printing Opportunities Emerge for Cardiologists, Hospitals, and Device Companies Alike

Yael L. Maxwell

October 31, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2017

Caitlin E. Cox

August 31, 2017

News Features

A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease

Yael L. Maxwell

August 02, 2017

News Conference News TVT 2017

Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated

Michael O'Riordan

June 16, 2017

Presentation TVT 2017

Prevalence of Amyloid in Patients Undergoing TAVR: Low-Flow Phenotype and Echocardiographic Predictors

Presenter: David J. Cohen, Mark J. Russo, Adam Castano

June 16, 2017

Presentation TVT 2017

TAVR to Treat Aortic Regurgitation in LVAD Patients Rationale and Case Examples

Presenter: David J. Cohen, Mark J. Russo, Nir Uriel

June 16, 2017

Presentation TVT 2017

Emergent TAVR for AS Patients With Intractable Heart Failure: Feasibility and Early Clinical Results

Presenter: David J. Cohen, Mark J. Russo, Ran Kornowski

June 16, 2017

Presentation TVT 2017

Who Shouldnt Undergo TAVR? Can We Identify Non-responders?

Presenter: David J. Cohen, Mark J. Russo, Suzanne V. Arnold

June 16, 2017

Presentation TVT 2017

Ineffective Endocarditis After TAVR: Cause for Concern?

Presenter: David J. Cohen, Mark J. Russo, Bernard Prendergast

June 16, 2017

Presentation TVT 2017

Gender Differences in TAVR Outcomes Recent Analyses in Intermediate-Risk Patients

Presenter: David J. Cohen, Mark J. Russo, Molly Szerlip

June 16, 2017

Presentation TVT 2017

TAVR in Patients With CKD: Diagnostic Workup, Valve Sizing, and Other Procedural Adjustments

Presenter: Howard C. Herrmann

June 16, 2017

Presentation TVT 2017

Management of Acute Coronary Syndromes and Left Main CAD in AS Patients: Case Examples and Procedural Techniques

Presenter: Raj Makkar

June 16, 2017

Presentation TVT 2017

Management of Stable Coronary Disease in AS Patients: Evolving Treatment Considerations (When to Consider CABG, Timing of PCI With TAVR, and Completeness of Revascularization)

Presenter: Jean-Michel Paradis

June 16, 2017

Presentation TVT 2017

The Role of MitraClip Therapy After TAVR Treatment Paradigms (Who, When, and How)

Presenter: Brij Maini

June 16, 2017

Advertisement

TAVR Learning Curve, Volume-Outcome Relationship Highlighted in International Registry

‘We Have to Go to Them’: New Global Initiative for Treating Rheumatic Heart Disease

Updated TAVR Consensus Statement Keeps Volume Requirements but Shifts Focus to Quality

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Cardiologists Treating Syrian Refugees Call Missions an ‘Addictive’ Passion That Saves Lives

Low Rate of Bailout Emergency Surgery During TAVR, but Caution Still Needed

3-D Printing Opportunities Emerge for Cardiologists, Hospitals, and Device Companies Alike

TCTMD’s Top 10 Most Popular Stories for August 2017

A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease

Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated

Prevalence of Amyloid in Patients Undergoing TAVR: Low-Flow Phenotype and Echocardiographic Predictors

TAVR to Treat Aortic Regurgitation in LVAD Patients Rationale and Case Examples

Emergent TAVR for AS Patients With Intractable Heart Failure: Feasibility and Early Clinical Results

Who Shouldnt Undergo TAVR? Can We Identify Non-responders?

Ineffective Endocarditis After TAVR: Cause for Concern?

Gender Differences in TAVR Outcomes Recent Analyses in Intermediate-Risk Patients

TAVR in Patients With CKD: Diagnostic Workup, Valve Sizing, and Other Procedural Adjustments

Management of Acute Coronary Syndromes and Left Main CAD in AS Patients: Case Examples and Procedural Techniques

Management of Stable Coronary Disease in AS Patients: Evolving Treatment Considerations (When to Consider CABG, Timing of PCI With TAVR, and Completeness of Revascularization)

The Role of MitraClip Therapy After TAVR Treatment Paradigms (Who, When, and How)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content